Merit Medical names Martha Aronson as CEO effective Oct 3; preliminary Q2 revenue up ~12-14% YoY

MERIT MEDICAL SYSTEMS INC

Martha Aronson appointed President and CEO effective Oct 3, 2025; founder Fred Lampropoulos remains Chairman.
Aronson previously EVP & President of Global Healthcare at Ecolab; 20 years at Medtronic.
Compensation: $1M base salary, $250K signing bonus, target bonus 100% of base, $5.5M initial LTI award, $4.125M equity grant.
Preliminary Q2 2025 revenue $380-384M, up 12-14% YoY; constant currency up 11-13%.
Full Q2 earnings release scheduled for July 30, 2025 after market close.

item 2.02item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.